Last 14,700 KRW
Change Today 0.00 / 0.00%
Volume 61.3K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 1:13 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Daewon Pharmaceutical Co. Ltd. uses little or no debt in its capital structure and may have less financial risk than the industry aggregate. Accounts Receivable are typical for the industry, with 65.65 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 104.07 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2010
Press
Release

KRW
Dec 31
2011
KRW
Dec 31
2012
KRW
Dec 31
2013
KRW
4 Year
Trend
Assets    
Cash and Equivalents--17,610.624,015.919,030.2
Short-Term Investments------7,806.2
TOTAL CASH AND SHORT TERM INVESTMENTS13,798.117,610.624,015.926,836.4
Accounts Receivable--31,713.529,258.027,894.2
Notes Receivable--597.0499.167.6
Other Receivables--3,281.52,679.44,429.3
TOTAL RECEIVABLES--35,592.032,436.532,391.1
Inventory--15,030.718,740.124,084.8
Prepaid Expenses--148.185.095.7
Other Current Assets--20.277.9232.1
TOTAL CURRENT ASSETS--68,401.675,355.483,640.0
Gross Property Plant and Equipment--76,614.179,930.589,434.3
Accumulated Depreciation---19,621.4-22,564.0-25,506.7
NET PROPERTY PLANT AND EQUIPMENT--56,992.757,366.563,927.6
Goodwill--1,988.01,988.01,758.3
Long-Term Investments--2,118.81,997.9932.4
Accounts Receivable, Long Term------0.0
Loans Receivable, Long Term--468.5----
Deferred Tax Assets, Long Term----13.758.6
Deferred Charges, Long Term--5,453.94,152.03,435.2
Other Intangibles--3,853.93,587.32,984.0
Other Long-Term Assets--1,110.62,664.73,404.0
TOTAL ASSETS--140,388.1147,125.4160,139.9
    
LIABILITIES & EQUITY    
Accounts Payable--4,454.35,754.45,741.8
Accrued Expenses--7,459.16,410.47,443.2
Short-Term Borrowings--6,200.03,000.03,000.0
Current Income Taxes Payable--548.3558.52,124.8
Other Current Liabilities, Total--7,060.37,958.16,783.9
TOTAL CURRENT LIABILITIES--25,721.923,681.325,093.7
Minority Interest--181.7529.9740.3
Pension & Other Post-Retirement Benefits--8,145.67,277.69,020.1
Deferred Tax Liability Non-Current--2,603.93,241.72,774.7
Other Non-Current Liabilities--0.00.00.0
TOTAL LIABILITIES--36,471.434,200.636,888.4
Common Stock--6,454.87,092.77,794.4
Additional Paid in Capital--12,366.012,356.511,641.9
Retained Earnings--85,855.093,407.5103,693.1
Treasury Stock---572.8-574.1-579.3
Comprehensive Income and Other---368.2112.2-39.0
TOTAL COMMON EQUITY93,670.3103,734.9112,394.9122,511.2
TOTAL EQUITY93,670.3103,916.6112,924.9123,251.5
TOTAL LIABILITIES AND EQUITY--140,388.1147,125.4160,139.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 14,700.00 KRW 0.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 15.3x
Price/Sales 1.3x
Price/Book 1.7x
Price/Cash Flow 15.2x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.